O. YILDIZ Et Al. , "Paritaprevir/ritonavirombitasvir dasabuvir (PrOD) with or without ribavirin treatment in hemodiyalysis patients with chronic hepatitis C virus infection," APASL2017 , 2017
YILDIZ, O. Et Al. 2017. Paritaprevir/ritonavirombitasvir dasabuvir (PrOD) with or without ribavirin treatment in hemodiyalysis patients with chronic hepatitis C virus infection. APASL2017 .
YILDIZ, O., AYGEN, B., GÖKAHMETOĞLU, S., TÜRE, Z., BALTACI, S., & TOK, T., (2017). Paritaprevir/ritonavirombitasvir dasabuvir (PrOD) with or without ribavirin treatment in hemodiyalysis patients with chronic hepatitis C virus infection . APASL2017
YILDIZ, ORHAN Et Al. "Paritaprevir/ritonavirombitasvir dasabuvir (PrOD) with or without ribavirin treatment in hemodiyalysis patients with chronic hepatitis C virus infection," APASL2017, 2017
YILDIZ, ORHAN Et Al. "Paritaprevir/ritonavirombitasvir dasabuvir (PrOD) with or without ribavirin treatment in hemodiyalysis patients with chronic hepatitis C virus infection." APASL2017 , 2017
YILDIZ, O. Et Al. (2017) . "Paritaprevir/ritonavirombitasvir dasabuvir (PrOD) with or without ribavirin treatment in hemodiyalysis patients with chronic hepatitis C virus infection." APASL2017 .
@conferencepaper{conferencepaper, author={ORHAN YILDIZ Et Al. }, title={Paritaprevir/ritonavirombitasvir dasabuvir (PrOD) with or without ribavirin treatment in hemodiyalysis patients with chronic hepatitis C virus infection}, congress name={APASL2017}, city={}, country={}, year={2017}}